These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 9385881

  • 1. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?
    Uretsky BF, Sheahan RG.
    J Am Coll Cardiol; 1997 Dec; 30(7):1589-97. PubMed ID: 9385881
    [Abstract] [Full Text] [Related]

  • 2. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F, Olivotto I.
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract] [Full Text] [Related]

  • 3. Sudden death in heart failure patients: effects of optimized medical therapy.
    Kao W, Costanzo MR.
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S32-7. PubMed ID: 11016485
    [Abstract] [Full Text] [Related]

  • 4. Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.
    Packer M.
    JACC Heart Fail; 2019 Oct; 7(10):902-906. PubMed ID: 31521684
    [No Abstract] [Full Text] [Related]

  • 5. [Congestive heart failure and arrhythmia].
    Kasanuki H.
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [Abstract] [Full Text] [Related]

  • 6. Heart failure.
    McKelvie R.
    Clin Evid; 2003 Jun; (9):95-118. PubMed ID: 12967355
    [No Abstract] [Full Text] [Related]

  • 7. Heart failure.
    McKelvie R.
    Clin Evid; 2004 Jun; (11):122-48. PubMed ID: 15652002
    [No Abstract] [Full Text] [Related]

  • 8. Heart failure.
    McKelvie R.
    Clin Evid; 2004 Dec; (12):115-43. PubMed ID: 15865633
    [No Abstract] [Full Text] [Related]

  • 9. [Heart failure].
    Yonezawa M, Komuro I.
    Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
    [Abstract] [Full Text] [Related]

  • 10. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY, Lim YZ, Hopper I, Krum H.
    Int J Cardiol; 2014 May 01; 173(2):197-203. PubMed ID: 24636548
    [Abstract] [Full Text] [Related]

  • 11. Outpatient management of pediatric heart failure.
    O'Connor MJ, Rosenthal DN, Shaddy RE.
    Heart Fail Clin; 2010 Oct 01; 6(4):515-29, ix. PubMed ID: 20869651
    [Abstract] [Full Text] [Related]

  • 12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec 01; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 13. [Practical aspects of diagnosis, treatment and prognosis in chronic heart failure].
    Wagdi P.
    Dtsch Med Wochenschr; 1999 Mar 12; 124(10):291-5. PubMed ID: 10191824
    [No Abstract] [Full Text] [Related]

  • 14. Editorial: Sudden death in heart failure: an ounce of prediction is worth a pound of prevention.
    Baliga RR, Young JB.
    Heart Fail Clin; 2011 Apr 12; 7(2):xiii-xviii. PubMed ID: 21439492
    [No Abstract] [Full Text] [Related]

  • 15. Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
    Grimm W, Maisch B.
    Herz; 2002 Dec 12; 27(8):750-9. PubMed ID: 12574892
    [Abstract] [Full Text] [Related]

  • 16. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.
    Packer M.
    Circ Arrhythm Electrophysiol; 2019 Jun 12; 12(6):e007430. PubMed ID: 31159583
    [No Abstract] [Full Text] [Related]

  • 17. Implantable cardioverter-defibrillators.
    Kukin ML.
    N Engl J Med; 2009 Feb 26; 360(9):937; author reply 937-8. PubMed ID: 19246371
    [No Abstract] [Full Text] [Related]

  • 18. Prediction and prevention of sudden cardiac death in heart failure.
    Lane RE, Cowie MR, Chow AW.
    Heart; 2005 May 26; 91(5):674-80. PubMed ID: 15831662
    [No Abstract] [Full Text] [Related]

  • 19. Heart failure.
    McKelvie R.
    Clin Evid; 2006 Jun 26; (15):118-39. PubMed ID: 16973007
    [No Abstract] [Full Text] [Related]

  • 20. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP, Hellkamp AS, Mark DB, Walsh MN, Poole JE, Anderson J, Johnson G, Lee KL, Bardy GH, SCD-HeFT Investigators.
    J Am Coll Cardiol; 2014 Jun 17; 63(23):2560-2568. PubMed ID: 24727258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.